Evidence map›Paper›PMID 30669786›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2018

[A real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir in the treatment of genotype 1b chronic hepatitis C].

J P Liu, Y Q Cheng, J M Zhang, H M Jin, H B Ning, K Li, M Y Ma, Y N Wu, Z Peng, H Yin and 2 more

Open access · greenAbstract read
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

J P LiuDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
Y Q ChengThe Fifth Medical Center of the General Hospital of the Chinese people's Liberation Army, BeiJing, 100039, China.
J M ZhangDepartment of Infectious Diseases, Huashan Hospital Affiliated to Fudan University, Shanghai, 200040, China.
H M JinDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
H B NingDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
K LiDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
M Y MaDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
Y N WuDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
Z PengDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
H YinDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
C P LiuDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
J ShangDepartment of Infectious Diseases, Henan Provincial People's Hospital, zhengzhou 450003, China.
Henan Provincial People's Hospital · CNFudan University · CN

Funding

Medical Science and Technology Research Project of HeNan Province 172102310068Provincial Joint Construction Program, Medical Science and Technology Research Program of Henan Province 20140101015
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ritonavir2-NaphthylamineAnilidesAntiviral AgentsCarbamatesChinaCyclopropanesDrug Therapy, CombinationGenotypeHepacivirusHepatitis C, ChronicHumansLactams, MacrocyclicMacrocyclic CompoundsMaleMiddle Aged2-NaphthylamineAnilidesAntiviral AgentsCarbamatesCyclopropanesdasabuvirLactams, MacrocyclicMacrocyclic CompoundsombitasvirparitaprevirProlineRibavirinRitonavirSulfonamidesUracilValineChronic hepatitis CDirect acting antiviral agentsDSVOBV/PTV/RTVTherapy

Identifiers

PMID30669786
PMCPMC12769687
OpenAlexW3024492626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.